Joanna Tengbom Hummel

Joanna Tengbom Hummel is a declared insider of Apotea AB (publ), with filings sourced from Finansinspektionen. Between 5 December 2024 and 3 June 2026, the trades on record add up to 5 filings.

No open-market sale appears; the market trades are 4 purchases worth €85k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 3 purchases and no sales.

Half of the purchases are above €23k and half below. Scaled by market value, the purchases weigh a median 0.0033% of market cap (sample: 3 purchases). Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 8 June 2026, reports an open-market purchase of €23k in Apotea AB (publ). Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.